Frequency of Hypoglycemia in Patients Presenting with Liver Cirrhosis
DOI:
https://doi.org/10.70749/ijbr.v3i6.3172Keywords:
Liver cirrhosis, hypoglycemia, glucose metabolism, prevalence, cross-sectional studyAbstract
Background: Liver cirrhosis is a chronic progressive disease associated with impaired metabolic function, including disturbances in glucose homeostasis such as hypoglycemia. Objective: To determine the frequency of hypoglycemia in patients with liver cirrhosis presenting to a tertiary care hospital. Methods: This cross-sectional study included 150 patients with liver cirrhosis, aged 30–75 years, conducted at a tertiary care hospital over six months. Hypoglycemia was defined as fasting blood glucose <70 mg/dL. It was observed in 76 patients, yielding a frequency of 50.7%, with higher rates in older age, males, low BMI, and low socioeconomic status. Conclusion: Hypoglycemia is highly prevalent among patients with liver cirrhosis and is associated with demographic and nutritional factors, highlighting the need for routine monitoring and early intervention. Venous blood samples were analyzed for fasting glucose, and data were processed using SPSS with stratification for demographic and clinical variables. Statistical analysis showed significant associations between hypoglycemia and age, gender, BMI, socioeconomic status, and rural residence. These findings suggest that hypoglycemia is a common metabolic complication in cirrhosis requiring vigilant monitoring, particularly in decompensated or malnourished patients. It represents an under-recognized predictor of poor prognosis and may overlap clinically with hepatic encephalopathy, complicating diagnosis. Routine glucose monitoring and early correction strategies are recommended to reduce morbidity and improve outcomes in affected patients. Overall, the study provides locally relevant evidence on the burden of hypoglycemia in cirrhosis, supporting integration of metabolic screening into routine clinical assessment, especially in resource-limited settings with high prevalence of advanced liver disease patient management strategies.
Downloads
References
1. Rodimova S, Mozherov A, Elagin V, Karabut M, Shchechkin I, Kozlov D, Krylov D, Gavrina A, Bobrov N, Zagainov V, Zagaynova E. Effect of hepatic pathology on liver regeneration: the main metabolic mechanisms causing impaired hepatic regeneration. International Journal of Molecular Sciences. 2023 May 23;24(11):9112.
https://doi.org/10.3390/ijms24119112
2. Somnay K, Wadgaonkar P, Sridhar N, Roshni P, Rao N, Wadgaonkar R. Liver fibrosis leading to cirrhosis: basic mechanisms and clinical perspectives. Biomedicines. 2024 Sep 30;12(10):2229.
https://doi.org/10.3390/biomedicines12102229
3. Wu XN, Xue F, Zhang N, Zhang W, Hou JJ, Lv Y, Xiang JX, Zhang XF. Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019. BMC Public Health. 2024 Feb 3;24(1):363.
https://doi.org/10.1186/s12889-024-17948-6
4. Younossi ZM, Wong G, Anstee QM, Henry L. The global burden of liver disease. Clinical Gastroenterology and Hepatology. 2023 Jul 1;21(8):1978-91.
https://doi.org/10.1016/j.cgh.2023.04.015
5. Vetrano E, Rinaldi L, Mormone A, Giorgione C, Galiero R, Caturano A, Nevola R, Marfella R, Sasso FC. Non-alcoholic fatty liver disease (NAFLD), type 2 diabetes, and non-viral hepatocarcinoma: pathophysiological mechanisms and new therapeutic strategies. Biomedicines. 2023 Feb 6;11(2):468.
https://doi.org/10.3390/biomedicines11020468
6. Henry L, Paik J, Younossi ZM. the epidemiologic burden of non‐alcoholic fatty liver disease across the world. Alimentary pharmacology & therapeutics. 2022 Sep;56(6):942-56.
https://doi.org/10.1111/apt.17158
7. Gines P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398(10308):1359-76.
https://doi.org/10.1016/s0140-6736(21)01374-x
8. Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, et al. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. J Gastroenterol. 2021;56(7):593-619.
https://doi.org/10.1007/s00535-021-01788-x
9. Morales-Galicia AE, Ramírez-Mejía MM, Ponciano-Rodriguez G, Méndez-Sánchez N. Revolutionizing the understanding of liver disease: Metabolism, function and future. World Journal of Hepatology. 2024 Dec 27;16(12):1365.
https://doi.org/10.4254/wjh.v16.i12.1365
10. Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M. Evidence-based clinical practice guidelines for liver cirrhosis 2020. Journal of gastroenterology. 2021 Jul;56(7):593-619.
https://doi.org/10.1007/s00535-021-01788-x
11. Quiroz-Aldave JE, Gamarra-Osorio ER, del Carmen Durand-Vásquez M, del Pilar Rafael-Robles L, Gonzáles-Yovera JG, Quispe-Flores MA, Concepción-Urteaga LA, Román-González A, Paz-Ibarra J, Concepción-Zavaleta MJ. From liver to hormones: The endocrine consequences of cirrhosis. World Journal of Gastroenterology. 2024 Mar 7;30(9):1073.
https://doi.org/10.3748/wjg.v30.i9.1073
12. Hung TH, Tseng CW, Tsai CC, Lee HF. Prognosis of hypoglycemia episode in cirrhotic patients during hospitalization. BMC gastroenterology. 2021 Aug 9;21(1):319.
https://doi.org/10.1186/s12876-021-01895-2
13. Hölzen L, Schultes B, Meyhöfer SM, Meyhöfer S. Hypoglycemia unawareness—a review on pathophysiology and clinical implications. Biomedicines. 2024 Feb 8;12(2):391.
https://doi.org/10.3390/biomedicines12020391
14. Faradji RN, Uribe-Wiechers AC, de la Maza ES. Hypoglycemia: Diagnosis, management, and prevention. InThe Diabetes Textbook: Clinical Principles, Patient Management and Public Health Issues 2023 Jun 3 (pp. 711-738). Cham: Springer International Publishing.
https://doi.org/10.1007/978-3-031-25519-9_45
15. Berumen J, Baglieri J, Kisseleva T, Mekeel K. Liver fibrosis: Pathophysiology and clinical implications. J Gastroenterol. 2021;13(1):e1499.
https://doi.org/10.1002/wsbm.1499
16. Nakhleh A, Shehadeh N. Hypoglycemia in diabetes: An update on pathophysiology, treatment, and prevention. World J Diabetes. 2021;12(12):2036-42.
https://doi.org/10.4239/wjd.v12.i12.2036
17. Mandl J. Glycogen—endoplasmic reticulum connection in the liver. International Journal of Molecular Sciences. 2023 Jan 5;24(2):1074.
https://doi.org/10.3390/ijms24021074
18. Soon GS, Torbenson M. The liver and glycogen: in sickness and in health. International journal of molecular sciences. 2023 Mar 24;24(7):6133.
https://doi.org/10.3390/ijms24076133
19. Kumar R, Prakash SS, Priyadarshi RN, Anand U. Sarcopenia in chronic liver disease: a metabolic perspective. Journal of clinical and translational hepatology. 2022 Aug 9;10(6):1213.
https://doi.org/10.14218/jcth.2022.00239
20. Coman LI, Coman OA, Bădărău IA, Păunescu H, Ciocîrlan M. Association between liver cirrhosis and diabetes mellitus: a review on hepatic outcomes. Journal of clinical medicine. 2021 Jan 12;10(2):262.
https://doi.org/10.3390/jcm10020262
21. Przezak A, Bielka W, Molęda P. Fear of hypoglycemia-An underestimated problem. Brain Behav. 2022;12(7):263-9.
https://doi.org/10.1002/brb3.2633
22. Hung TH, Tseng CW, Tsai CC, Lee HF. Prognosis of hypoglycemia episode in cirrhotic patients during hospitalization. Gastroenterology. 2021;21(17):319-23.
https://doi.org/10.1186/s12876-021-01895-2
23. Saiman Y, Mahmud N. Hypoglycemia is an early, independent predictor of bacteremia and in-hospital death in patients with cirrhosis. Eur J Gastroenterol Hepatol. 2021;33(12):693-9.
https://doi.org/10.1097/meg.0000000000002218
24. Majeed A, Arafat MY, Ali I. Hypoglycemia in patients presenting with Liver Cirrhosis. Pak J Med Health Sci. 2017;11(4):1211-3.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research

This work is licensed under a Creative Commons Attribution 4.0 International License.